Ascorbic acid Recruiting Phase 2 Trials for Myelodysplastic Syndromes / Leukemia Acute Myeloid Leukemia (AML) / Myeloproliferative Neoplasms Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03397173TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid